Company / Current Liabilities per Share
Neurocrine Biosciences Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$7.48
FY2025
5-year range
$2.63 / $7.48
FY2021-FY2025
Trend
+45.4%
vs FY2024
Sector context
#28 of 212
Health Care
What the data says
Neurocrine Biosciences's current liabilities per share of $7.48 is higher than 87% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.35 in FY2016 to $7.48 in FY2025.
Based on SEC 10-K filings.
7.48 in FY2025 with a 5-year CAGR of +29.9%. Top quartile in the Health Care sector.
Increased from $6.79 to $7.48 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Sector benchmark
-52.2% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 45.4% year-over-year.
- Ranks #28 out of 212 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.48 | +45.4% |
| FY2024 | $5.14 | -24.2% |
| FY2023 | $6.79 | +19.8% |
| FY2022 | $5.67 | +115.5% |
| FY2021 | $2.63 | +30.1% |
| FY2020 | $2.02 | -67.5% |
| FY2019 | $6.23 | +526.6% |
| FY2018 | $0.99 | +58.6% |
| FY2017 | $0.63 | +77.7% |
| FY2016 | $0.35 | +4.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026